Obliteride funding matters at Fred Hutch — and our generous sponsors ensure that 100% of every dollar you raise goes right to work. In the last 10 years, we’ve fueled new approaches for breast, colon, pancreatic and prostate cancer. Advanced new breakthroughs in immunotherapy and data science. Supported community partnerships to improve health. Sparked urgently needed leadership in the response to COVID-19 and other infectious diseases. And helped Fred Hutch attract the world’s top researchers and nurture their most innovative work.
Since 2013, Obliteride funding has supported more than 200 projects and more than 65 world-leading researchers — kickstarting a wheel of innovation that leads to even more discoveries over time. Here are three examples:
In 2017, we supported Dr. Roland Strong to improve cancer treatment by helping create a tool that identifies “targets” present in cancer cells, but not healthy cells.
Today, we’re supporting Dr. Aude Chapuis, holder of the John C. and Karyl Kay Hughes Endowed Chair, as she builds on this work: retraining the body’s own immune cells to recognize targets and attack cancers.
With Obliteride funding, Dr. Jen Adair holder of the Fleischauer Family Endowed Chair in Gene Therapy Translation developed a groundbreaking technology to make gene therapies for cancer more accessible worldwide.
Dr. Hootie Warren continues to help improve treatment around the world, especially in communities with limited access to care.
With early funding from Obliteride, Dr. Johanna Lampe identified nutrients associated with cancer risk, unlocking new insights into diet and risk reduction.
Now, we’re helping Dr. Heather Greenlee continue to improve health and nutrition. Her website, Cook for Your Life, provides science-based recipes to reduce risk, address challenges during treatment, and more.
When you Obliteride, every dollar you raise directly supports Fred Hutch. Meet the scientists — and research — you support.
Have fun and help cure cancer faster! We can't wait to have you join us.